# Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma

> **NCT06623474** · — · RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 900 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** diagnosed by traditional diagnostic markers（such as AFP or CT etc.）

## Key facts

- **NCT ID:** NCT06623474
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2032-06-30
- **Final completion:** 2032-07-01
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623474, "Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06623474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*